5XR-82885-11377
5 vaccinations
5 coded responses
49 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 662 / KS
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-21
Dose 1 — Pfizer-BioNTech
-
2021-01-22
Registered in v-safe
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-02-04
-
2021-02-11
Dose 2 — Pfizer-BioNTech
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-19
- 2021-03-25
- 2021-05-13
- 2021-08-14
-
2021-10-12
Dose 3 — Pfizer-BioNTech
-
2021-10-27
Survey response — day 14, dose 3MedDRA: Fatigue, Muscular weakness, Myalgia, Pain in extremity, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: After booster had pain in arm , fever for 2 days,muscle aches and muscle weakness in lower extremities for 48 hrs and feeling tired for several days. Feeling better now No problems with 1 and 2 shotsMedDRA releases: 2024-11 · check-in free text available
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2021-11-23
-
2022-01-11
Survey response — 3 months, dose 3MedDRA: Pain in extremity — Feeling: FairFree text: Some pain in LLE of low intensity that just started Sunday eveningMedDRA releases: 2024-11 · check-in free text available
-
2022-04-12
Dose 4 — Pfizer-BioNTech
- 2022-04-12
-
2022-04-13
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-14
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-04-15
- 2022-04-16
- 2022-04-17
- 2022-04-18
- 2022-04-19
- 2022-04-26
- 2022-05-05
- 2022-05-14
- 2022-05-17
- 2022-05-25
-
2022-10-03
Dose 5 — Pfizer-BioNTech
-
2022-10-12
Survey response — 6 months, dose 4MedDRA: Arthralgia, Hyperhidrosis, Injection site pain, Injection site swelling, Malaise, Myalgia — Feeling: Good · Be unable to do your normal daily activitiesFree text: After 5th shot (3rd booster) had pain and swelling in area of shot and general malaise for 24 -26 hrs with sweating and muscle and joint pain. Then Back to normalMedDRA releases: 2024-11 · check-in free text available
-
2022-10-17
Survey response — day 14, dose 5MedDRA: Arthralgia, Injection site pain, Malaise, Mobility decreased — Feeling: Good · Be unable to do your normal daily activitiesFree text: I spent 1 day in bed not feeling well and pain in injection site with aches in major jointsMedDRA releases: 2024-11 · check-in free text available
- 2022-10-24
- 2022-10-31
- 2022-11-07
-
2022-11-14
Survey response — day 42, dose 5MedDRA: Fatigue — Feeling: FairFree text: Feeling tiredMedDRA releases: 2024-11 · check-in free text available
- 2023-01-02
- 2023-04-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Pfizer-BioNTech | |
| 2 | 2021-02-11 | Pfizer-BioNTech | |
| 3 | 2021-10-12 | Pfizer-BioNTech | No |
| 4 | 2022-04-12 | Pfizer-BioNTech | No |
| 5 | 2022-10-03 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 3
Symptoms: After booster had pain in arm , fever for 2 days,muscle aches and muscle weakness in lower extremities for 48 hrs and feeling tired for several days. Feeling better now No problems with 1 and 2 shots
Release 10 — 3 months, dose 3
Symptoms: Some pain in LLE of low intensity that just started Sunday evening
Release 12 — 6 months, dose 4
Symptoms: After 5th shot (3rd booster) had pain and swelling in area of shot and general malaise for 24 -26 hrs with sweating and muscle and joint pain. Then Back to normal
Release 12 — day 14, dose 5
Symptoms: I spent 1 day in bed not feeling well and pain in injection site with aches in major joints
Release 12 — day 42, dose 5
Symptoms: Feeling tired
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hyperhidrosis | · | · | ✓ |
| SD | Injection site pain | · | · | ✓ |
| SD | Injection site swelling | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release